TLR2 signaling renders quiescent naive and memory CD4+ T cells more susceptible to productive infection with X4 and R5 HIV-type 1

J Immunol. 2007 Oct 1;179(7):4357-66. doi: 10.4049/jimmunol.179.7.4357.

Abstract

It has been recently demonstrated that circulating microbial products are responsible for a systemic immune activation in individuals infected with HIV-type 1. Bacterial products carry structural conserved motifs recognized by TLRs. Some TLR members are expressed in primary human CD4+ T cells but the precise functional role played by these pattern recognition receptors is still imprecise. In this study, we report that engagement of TLR2 in quiescent naive and memory CD4+ T cells leads to the acquisition of an effector-like phenotype. Interestingly, engagement of TLR2 renders both cell subsets more susceptible to productive infection with X4 virions and a higher virus production was seen with R5 viruses. It can be proposed that exposure of resting CD4+ T cells to pathogen-derived products that can engage TLR2 induces the acquisition of an effector-like phenotype in naive and memory CD4+ T lymphocytes, a phenomenon that might result in an acceleration of virus replication, immune dysregulation, and HIV-type 1-mediated disease progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / pathology
  • Cell Line
  • Cell Separation
  • Disease Susceptibility
  • HIV Infections / immunology*
  • HIV Infections / metabolism
  • HIV Infections / pathology*
  • HIV Infections / virology
  • HIV-1 / physiology
  • Humans
  • Immunity, Innate / immunology*
  • Immunologic Memory / immunology*
  • NF-kappa B / metabolism
  • Receptors, CCR5 / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / immunology*
  • Toll-Like Receptor 2 / agonists
  • Toll-Like Receptor 2 / metabolism*
  • Virion / metabolism
  • Virus Replication

Substances

  • Biomarkers
  • NF-kappa B
  • Receptors, CCR5
  • Toll-Like Receptor 2